More importantly, Liu et al. showed that EP300 inhibition reduced tumor growth in wild type, but not immune-deficient mice and increased tumor infiltration as well as activity of cytotoxic T cells and decreased Tregs40. The gene discussed is EP300; the disease is neoplasm.